Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
ASPC manual of preventive cardiology / / editors, Nathan D. Wong, Ezra A. Amsterdam, and Roger S. Blumenthal
| ASPC manual of preventive cardiology / / editors, Nathan D. Wong, Ezra A. Amsterdam, and Roger S. Blumenthal |
| Pubbl/distr/stampa | New York : , : demosMEDICAL, , 2015 |
| Descrizione fisica | 1 online resource (295 p.) |
| Disciplina | 616.1/05 |
| Soggetto topico | Cardiovascular system - Diseases - Prevention |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61705-141-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Foreword; Preface; Acknowledgments; Share ASPC Manual of Preventive Cardiology; Chapter 1: National Burden of Cardiovascular Disease and Associated Risk Factors; Cardiovascular Disease; Mortality and Morbidity Attributable to CVD; Prevalence and Control of Cardiovascular Risk Factors; Subclinical Atherosclerosis; Ankle-Brachial Index; Economic Costs of Cardiovascular Disease; Summary; Acknowledgments; References; Chapter 2: Cardiovascular Risk Assessment; Rationale for Contemporary CV Risk Prediction
Relative Risk Versus Absolute Cardiovascular RiskTreatment Benefit Depends on Absolute Risk Rather Than Relative Risk; Multiple, Online Risk Prediction Tools for CVD are Widely Available; Current Guideline Recommendations; Current Clinical Practice Guidelines Suggest That the Indication and Intensity of Treatment Should Be Proportional to the Absolute Risk for CVD; Novel Developments in Global CVD Risk: Considering Alternative CVD Outcomes; Novel Developments in Global CVD Risk: Considering Alternative Risk Factors; Novel Serum Markers; Novel Imaging Markers; Other Risk Markers Novel Developments in Global CVD Risk: Considering Long-Term or Lifetime RiskConclusion; References; Chapter 3: The New American Prevention Guidelines: Aligning the Guidelines for Atherosclerotic Cardiovascular Risk Reduction With the Evidence; A New Approach; Major Themes; What You Need to Know; A. Heart Healthy Nutrition and Physical Activity Behaviors; B. Recommendations from the Risk Assessment Workgroup With Those Reflecting Expert Opinion Highlighted in Italics; C. Graded Recommendations for Statin Treatment to Reduce ASCVD Risk Footnotes to this Section (from the Cholesterol Guideline Report)Statin Safety Recommendations; Footnotes to this Section (from the Cholesterol Guideline Report); Monitoring Statin Therapy; Optimizing Statin Therapy; Insufficient Response to Statin Therapy; Footnotes to this Section (from the Cholesterol Guideline Report); Conclusions; References; Chapter 4: Management of High Blood Pressure; Epidemiology of Hypertension; Definition and Classification of Hypertension; Initial Evaluation of the Patient; Thresholds for Initiating Therapy; Lifestyle Modifications; Initial Drug Therapy Goal Blood Pressure for "Uncomplicated" Hypertensive PatientsGoal Blood Pressure for Hypertensive Patients with Other High-Risk Conditions; Other Issues; References; Chapter 5: Smoking and Passive Smoking; Smoking and Cardiovascular Disease; Secondhand Smoke; Trends in Cigarette Smoking; Prevention and Reduction of Tobacco Use Among Youth; Prevention and Cessation Programs for Adults; Cessation Strategies for Individuals; Behavioral Treatments; Pharmacologic Interventions; Clinical Approaches; Conclusions; References; Chapter 6: Metabolic Syndrome; History, Prevalence, and Epidemiology Definition |
| Record Nr. | UNINA-9910463373803321 |
| New York : , : demosMEDICAL, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
ASPC manual of preventive cardiology / / editors, Nathan D. Wong, Ezra A. Amsterdam, and Roger S. Blumenthal
| ASPC manual of preventive cardiology / / editors, Nathan D. Wong, Ezra A. Amsterdam, and Roger S. Blumenthal |
| Pubbl/distr/stampa | New York : , : demosMEDICAL, , 2015 |
| Descrizione fisica | 1 online resource (295 p.) |
| Disciplina | 616.1/05 |
| Soggetto topico | Cardiovascular system - Diseases - Prevention |
| ISBN | 1-61705-141-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Foreword; Preface; Acknowledgments; Share ASPC Manual of Preventive Cardiology; Chapter 1: National Burden of Cardiovascular Disease and Associated Risk Factors; Cardiovascular Disease; Mortality and Morbidity Attributable to CVD; Prevalence and Control of Cardiovascular Risk Factors; Subclinical Atherosclerosis; Ankle-Brachial Index; Economic Costs of Cardiovascular Disease; Summary; Acknowledgments; References; Chapter 2: Cardiovascular Risk Assessment; Rationale for Contemporary CV Risk Prediction
Relative Risk Versus Absolute Cardiovascular RiskTreatment Benefit Depends on Absolute Risk Rather Than Relative Risk; Multiple, Online Risk Prediction Tools for CVD are Widely Available; Current Guideline Recommendations; Current Clinical Practice Guidelines Suggest That the Indication and Intensity of Treatment Should Be Proportional to the Absolute Risk for CVD; Novel Developments in Global CVD Risk: Considering Alternative CVD Outcomes; Novel Developments in Global CVD Risk: Considering Alternative Risk Factors; Novel Serum Markers; Novel Imaging Markers; Other Risk Markers Novel Developments in Global CVD Risk: Considering Long-Term or Lifetime RiskConclusion; References; Chapter 3: The New American Prevention Guidelines: Aligning the Guidelines for Atherosclerotic Cardiovascular Risk Reduction With the Evidence; A New Approach; Major Themes; What You Need to Know; A. Heart Healthy Nutrition and Physical Activity Behaviors; B. Recommendations from the Risk Assessment Workgroup With Those Reflecting Expert Opinion Highlighted in Italics; C. Graded Recommendations for Statin Treatment to Reduce ASCVD Risk Footnotes to this Section (from the Cholesterol Guideline Report)Statin Safety Recommendations; Footnotes to this Section (from the Cholesterol Guideline Report); Monitoring Statin Therapy; Optimizing Statin Therapy; Insufficient Response to Statin Therapy; Footnotes to this Section (from the Cholesterol Guideline Report); Conclusions; References; Chapter 4: Management of High Blood Pressure; Epidemiology of Hypertension; Definition and Classification of Hypertension; Initial Evaluation of the Patient; Thresholds for Initiating Therapy; Lifestyle Modifications; Initial Drug Therapy Goal Blood Pressure for "Uncomplicated" Hypertensive PatientsGoal Blood Pressure for Hypertensive Patients with Other High-Risk Conditions; Other Issues; References; Chapter 5: Smoking and Passive Smoking; Smoking and Cardiovascular Disease; Secondhand Smoke; Trends in Cigarette Smoking; Prevention and Reduction of Tobacco Use Among Youth; Prevention and Cessation Programs for Adults; Cessation Strategies for Individuals; Behavioral Treatments; Pharmacologic Interventions; Clinical Approaches; Conclusions; References; Chapter 6: Metabolic Syndrome; History, Prevalence, and Epidemiology Definition |
| Record Nr. | UNINA-9910787804503321 |
| New York : , : demosMEDICAL, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
ASPC manual of preventive cardiology / / editors, Nathan D. Wong, Ezra A. Amsterdam, and Roger S. Blumenthal
| ASPC manual of preventive cardiology / / editors, Nathan D. Wong, Ezra A. Amsterdam, and Roger S. Blumenthal |
| Pubbl/distr/stampa | New York : , : demosMEDICAL, , 2015 |
| Descrizione fisica | 1 online resource (295 p.) |
| Disciplina | 616.1/05 |
| Soggetto topico | Cardiovascular system - Diseases - Prevention |
| ISBN | 1-61705-141-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Foreword; Preface; Acknowledgments; Share ASPC Manual of Preventive Cardiology; Chapter 1: National Burden of Cardiovascular Disease and Associated Risk Factors; Cardiovascular Disease; Mortality and Morbidity Attributable to CVD; Prevalence and Control of Cardiovascular Risk Factors; Subclinical Atherosclerosis; Ankle-Brachial Index; Economic Costs of Cardiovascular Disease; Summary; Acknowledgments; References; Chapter 2: Cardiovascular Risk Assessment; Rationale for Contemporary CV Risk Prediction
Relative Risk Versus Absolute Cardiovascular RiskTreatment Benefit Depends on Absolute Risk Rather Than Relative Risk; Multiple, Online Risk Prediction Tools for CVD are Widely Available; Current Guideline Recommendations; Current Clinical Practice Guidelines Suggest That the Indication and Intensity of Treatment Should Be Proportional to the Absolute Risk for CVD; Novel Developments in Global CVD Risk: Considering Alternative CVD Outcomes; Novel Developments in Global CVD Risk: Considering Alternative Risk Factors; Novel Serum Markers; Novel Imaging Markers; Other Risk Markers Novel Developments in Global CVD Risk: Considering Long-Term or Lifetime RiskConclusion; References; Chapter 3: The New American Prevention Guidelines: Aligning the Guidelines for Atherosclerotic Cardiovascular Risk Reduction With the Evidence; A New Approach; Major Themes; What You Need to Know; A. Heart Healthy Nutrition and Physical Activity Behaviors; B. Recommendations from the Risk Assessment Workgroup With Those Reflecting Expert Opinion Highlighted in Italics; C. Graded Recommendations for Statin Treatment to Reduce ASCVD Risk Footnotes to this Section (from the Cholesterol Guideline Report)Statin Safety Recommendations; Footnotes to this Section (from the Cholesterol Guideline Report); Monitoring Statin Therapy; Optimizing Statin Therapy; Insufficient Response to Statin Therapy; Footnotes to this Section (from the Cholesterol Guideline Report); Conclusions; References; Chapter 4: Management of High Blood Pressure; Epidemiology of Hypertension; Definition and Classification of Hypertension; Initial Evaluation of the Patient; Thresholds for Initiating Therapy; Lifestyle Modifications; Initial Drug Therapy Goal Blood Pressure for "Uncomplicated" Hypertensive PatientsGoal Blood Pressure for Hypertensive Patients with Other High-Risk Conditions; Other Issues; References; Chapter 5: Smoking and Passive Smoking; Smoking and Cardiovascular Disease; Secondhand Smoke; Trends in Cigarette Smoking; Prevention and Reduction of Tobacco Use Among Youth; Prevention and Cessation Programs for Adults; Cessation Strategies for Individuals; Behavioral Treatments; Pharmacologic Interventions; Clinical Approaches; Conclusions; References; Chapter 6: Metabolic Syndrome; History, Prevalence, and Epidemiology Definition |
| Record Nr. | UNINA-9910821507203321 |
| New York : , : demosMEDICAL, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiac adaptations : molecular mechanisms / / Bohuslav Ostadal, Naranjan S. Dhalla, editors
| Cardiac adaptations : molecular mechanisms / / Bohuslav Ostadal, Naranjan S. Dhalla, editors |
| Edizione | [1st ed. 2013.] |
| Pubbl/distr/stampa | New York, : Springer, 2013 |
| Descrizione fisica | 1 online resource (466 p.) |
| Disciplina | 616.1/05 |
| Altri autori (Persone) |
OstadalBohuslav
DhallaNaranjan S |
| Collana | Advances in biochemistry in health and disease |
| Soggetto topico | Cardiovascular system - Physiology |
| ISBN |
1-283-69721-1
1-4614-5203-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | pt. I. Developmental aspects of cardiac adaptation -- pt. II. Cardiac adaptations to overload -- pt. III. Molecular and cellular aspects of cardiac adaptations. |
| Record Nr. | UNINA-9910437825903321 |
| New York, : Springer, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
A nationwide framework for surveillance of cardiovascular and chronic lung diseases [[electronic resource] /] / Institute of Medicine of the National Academies
| A nationwide framework for surveillance of cardiovascular and chronic lung diseases [[electronic resource] /] / Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2011 |
| Descrizione fisica | xiii, 186 p. : ill. (some col.) |
| Disciplina | 616.1/05 |
| Soggetto topico |
Cardiovascular system - Diseases - Prevention
Cardiovascular system - Diseases - Risk factors Lungs - Diseases, Obstructive - Prevention Coronary heart disease - Prevention |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-283-27873-1
9786613278739 0-309-21217-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910457062103321 |
| Washington, D.C., : National Academies Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
A nationwide framework for surveillance of cardiovascular and chronic lung diseases [[electronic resource] /] / Institute of Medicine of the National Academies
| A nationwide framework for surveillance of cardiovascular and chronic lung diseases [[electronic resource] /] / Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2011 |
| Descrizione fisica | xiii, 186 p. : ill. (some col.) |
| Disciplina | 616.1/05 |
| Soggetto topico |
Cardiovascular system - Diseases - Prevention
Cardiovascular system - Diseases - Risk factors Lungs - Diseases, Obstructive - Prevention Coronary heart disease - Prevention |
| ISBN |
0-309-21219-7
1-283-27873-1 9786613278739 0-309-21217-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- Cardiovascular disease -- Chronic lung disease -- Health disparities -- Existing surveillance data sources and systems -- Levels of surveillance and emerging data sources -- Using surveillance data for action. |
| Record Nr. | UNINA-9910781895003321 |
| Washington, D.C., : National Academies Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
A nationwide framework for surveillance of cardiovascular and chronic lung diseases / / Institute of Medicine of the National Academies
| A nationwide framework for surveillance of cardiovascular and chronic lung diseases / / Institute of Medicine of the National Academies |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2011 |
| Descrizione fisica | xiii, 186 p. : ill. (some col.) |
| Disciplina | 616.1/05 |
| Soggetto topico |
Cardiovascular system - Diseases - Prevention
Cardiovascular system - Diseases - Risk factors Lungs - Diseases, Obstructive - Prevention Coronary heart disease - Prevention Cardiovascular Diseases - epidemiology Lung Diseases - epidemiology Chronic Disease - epidemiology Data Collection - methods Epidemiologic Methods Population Surveillance - methods |
| ISBN |
9786613278739
9780309212199 0309212197 9781283278737 1283278731 9780309212175 0309212170 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- Cardiovascular disease -- Chronic lung disease -- Health disparities -- Existing surveillance data sources and systems -- Levels of surveillance and emerging data sources -- Using surveillance data for action. |
| Record Nr. | UNINA-9910974330103321 |
| Washington, D.C., : National Academies Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nutraceuticals and human blood platelet function : applications in cardiovascular health / / by Asim K. Duttaroy
| Nutraceuticals and human blood platelet function : applications in cardiovascular health / / by Asim K. Duttaroy |
| Autore | Duttaroy Asim K. |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | Hoboken, NJ : , : Wiley, , 2018 |
| Descrizione fisica | 1 online resource (1 volume (unpaged)) |
| Disciplina | 616.1/05 |
| Soggetto topico |
Cardiovascular Diseases - prevention & control
Cardiovascular Diseases - etiology Dietary Supplements Functional Food Platelet Activation - physiology |
| ISBN |
1-119-37605-X
1-119-37600-9 1-119-37591-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Human blood platelets and their role in the development of cardiovascular disease -- Epidemiology of cardiovascular disease -- N-2 fatty acids and human platelets -- Effects of garlic, onion, ginger and tumeric on platelet function -- Herbs and platelet function -- Tomato extract and human platelet function -- Dietary nitrates and their antiplatelet effects -- Kiwifruit and human platelet function -- Polyphenols and human platelets -- Effects of ginkgo biloba, ginseng green tea, and dark chocolate on human blood platelet function -- Plant alkaloids and platelet function -- Strawberries and human platelet function -- Effects of metal ions on platelet function -- Individual compounds isolated from plant sources with anti-platelet activity. |
| Record Nr. | UNINA-9910270918203321 |
Duttaroy Asim K.
|
||
| Hoboken, NJ : , : Wiley, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nutraceuticals and human blood platelet function : applications in cardiovascular health / / by Asim K. Duttaroy
| Nutraceuticals and human blood platelet function : applications in cardiovascular health / / by Asim K. Duttaroy |
| Autore | Duttaroy Asim K. |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | Hoboken, NJ : , : Wiley, , 2018 |
| Descrizione fisica | 1 online resource (1 volume (unpaged)) |
| Disciplina | 616.1/05 |
| Soggetto topico |
Cardiovascular Diseases - prevention & control
Cardiovascular Diseases - etiology Dietary Supplements Functional Food Platelet Activation - physiology |
| ISBN |
1-119-37605-X
1-119-37600-9 1-119-37591-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Human blood platelets and their role in the development of cardiovascular disease -- Epidemiology of cardiovascular disease -- N-2 fatty acids and human platelets -- Effects of garlic, onion, ginger and tumeric on platelet function -- Herbs and platelet function -- Tomato extract and human platelet function -- Dietary nitrates and their antiplatelet effects -- Kiwifruit and human platelet function -- Polyphenols and human platelets -- Effects of ginkgo biloba, ginseng green tea, and dark chocolate on human blood platelet function -- Plant alkaloids and platelet function -- Strawberries and human platelet function -- Effects of metal ions on platelet function -- Individual compounds isolated from plant sources with anti-platelet activity. |
| Record Nr. | UNINA-9910808829403321 |
|
Duttaroy Asim K.
|
||
| Hoboken, NJ : , : Wiley, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||